NF-κB precursor, p105, and NF-κB inhibitor, IκBγ, are both elevated in Alzheimer disease brain

Neuroscience Letters

Volumn 373, Issue 2, 2005, Pages 115-118

  Huang, Yu ^a,b   Liu, Fei ^a   Grundke Iqbal, Inge ^a   Iqbal, Khalid ^a,b   Gong, Cheng Xin ^a,b  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b 365 Fifth Ave New York N   (United States)

Author keywords

Alzheimer disease; Human brain; I B ; NF B precursor

Indexed keywords

AGGLUTININ; I KAPPA B; I KAPPA B GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LECTIN; PROTEIN P105; PROTEIN PRECURSOR; PROTEIN SUBUNIT; UNCLASSIFIED DRUG; CELL NUCLEUS ANTIGEN; NFKB1 PROTEIN, HUMAN; NONHISTONE PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MAACKIA; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; STAINING; WESTERN BLOTTING; AMINO ACID SEQUENCE; BRAIN CORTEX; GENETICS; METABOLISM; POLYACRYLAMIDE GEL ELECTROPHORESIS;

AGED; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ANTIGENS, NUCLEAR; BLOTTING, WESTERN; CEREBRAL CORTEX; CHROMOSOMAL PROTEINS, NON-HISTONE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; I-KAPPA B PROTEINS; MASS SPECTROMETRY; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT;

EID: 9644294200     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.09.074     Document Type: Article

References (15)

1. 2+ accumulation Proc. Natl. Acad. Sci. U.S.A. 92 1995 9328 9332
2. S.M. Cardoso, and C.R. Oliveira Inhibition of NF-κB renders cells more vulnerable to apoptosis induced by amyloid beta peptides Free Radic. Res. 37 2003 967 973
3. R.J. Grumont, and S. Gerondakis Alternative splicing of RNA transcripts encoded by the murine p105 NF-kappa B gene generates I-kappa B gamma isoforms with different inhibitory activities Proc. Natl. Acad. Sci. U.S.A. 91 1994 4367 4371
4. E. Heron, and P. Deloukas A.P. van Loon, The complete exon-intron structure of the 156-kb human gene NF-κB1, which encodes the p105 and p50 proteins of transcription factors NF-kappa B and I-kappa B-gamma: implications for NF-kappa B-mediated signal transduction Genomics 30 1995 493 505
5. J. Inoue, L.D. Kerr, A. Kakizuka, and I.M. Verma IκBγ, a 70 kD protein identical to the C-terminal half of p110 NF-κB: a new member of the I κB family Cell 68 1992 1109 1120
6. B. Kaltschmidt, M. Uherek, B. Volk, P.A. Baeuerle, and C. Kaltschmidt Transcription factor NF-kappa B is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease Proc. Natl. Acad. Sci. U.S.A. 94 1997 2642 2647
7. F. Liu, K. Iqbal, I. Grundke-Iqbal, G.W. Hart, and C.-X. Gong O-GlcN acylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease Proc. Natl. Acad. Sci. U.S.A. 101 2004 10804 10809
8. F. Liu, T. Zaidi, I. Grundke-Iqbal, K. Iqbal, and C.-X. Gong Role of glycosylation in hyperphosphorylation of tau in Alzheimer's disease FEBS. Lett. 512 2002 101 106
9. E. Masliah, M. Mallory, M. Alford, L.A. Hansen, and T. Saitoh Immunoreactivity of the nuclear antigen p105 is associated with plaques and tangles in Alzheimer's disease Lab. Invest. 69 1993 562 569
10. J.H. Pazur Neutral polysaccharides M.F. Chaplin J.F. Kennedy Carbohydrate Analysis second ed. 1994 Oxford University Press New York 73 124
11. F. Rogerieux, M. Belaise, H. Terzidis-Trabelsi, A. Greffard, Y. Pilatte, and C.R. Lambre Determination of the sialic acid linkage specificity of sialidases using lectins in a solid phase assay Anal. Biochem. 211 1993 200 204
12. J.Z. Wang, I. Grundke-Iqbal, and K. Iqbal Glycosylation of microtubule-associated protein tau: an abnormal post-translational modification in Alzheimer's disease Nat. Med. 2 1996 871 875
13. V.P. Whittaker, I.A. Michaelson, and R.J.A. Kirkland The separation of synaptic vesicles from nerve-ending particles (synaptosomes) Biochem. J. 90 1964 293 303
14. S.D. Yan, S.F. Yan, X. Chen, J. Fu, M. Chen, P. Kuppusamy, M.A. Smith, G. Perry, G.C. Godman, and P. Nawroth Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide Nat. Med. 1 1995 693 699
15. Y. Yoshiyama, K. Arai, and T. Hattori Enhanced expression of I-kappa B with neurofibrillary pathology in Alzheimer's disease Neuroreport 12 2001 2641 2645